Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2026-05-21 17:06:21 ET · period of report 2026-05-19 · accession 0001193125-26-234853 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 17:06 | 2026-05-19 | CRBP | Jenkins John Kenneth | Dir | A - Grant | $0.00 | +3,800 | 8,633 | +79% | $0 |
| D | 2026-05-21 17:06 | 2026-05-19 | CRBP | Jenkins John Kenneth | Dir | A - Grant | $0.00 | +12.3K | 12.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-05-19 | A | A | 3,800 | $0.00 | 8,633 | D | — | — | (F1) On May 19, 2026, 3,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. (F2) This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported. |
| 2 | Derivative | Stock options (right to buy) | 2026-05-19 | A | A | 12,300 | $0.00 | 12,300 | D | $9.15 · — to 2026-05-19 | 12,300 Common Stock | (F3) The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant. |